Seagen Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SEAGEN, and when can generic versions of SEAGEN drugs launch?
SEAGEN has one approved drug.
There are seven US patents protecting SEAGEN drugs.
There are one hundred and ninety-one patent family members on SEAGEN drugs in forty-five countries and seventeen supplementary protection certificates in fifteen countries.
Summary for Seagen
| International Patents: | 191 |
| US Patents: | 7 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Seagen: | See patent lawsuits for Seagen |
Drugs and US Patents for Seagen
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-001 | Apr 17, 2020 | RX | Yes | No | 11,504,370 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-002 | Apr 17, 2020 | RX | Yes | Yes | 11,504,370 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-002 | Apr 17, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-002 | Apr 17, 2020 | RX | Yes | Yes | 9,457,093 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Seagen | TUKYSA | tucatinib | TABLET;ORAL | 213411-002 | Apr 17, 2020 | RX | Yes | Yes | 7,452,895 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Seagen Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20210131426 | ⤷ Try a Trial |
| Australia | 2019200243 | ⤷ Try a Trial |
| Israel | 261659 | ⤷ Try a Trial |
| Spain | 2335535 | ⤷ Try a Trial |
| New Zealand | 724544 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Seagen Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1971601 | C01971601/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: TUCATINIB; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67798 07.05.2020 |
| 1971601 | 2190026-1 | Sweden | ⤷ Try a Trial | PRODUCT NAME: TUCATINIB, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE; NAT. REG. NO/DATE: EU/20/1526 20210212; FIRST REG.: CH 67798 20200507 |
| 1971601 | 27/2021 | Austria | ⤷ Try a Trial | PRODUCT NAME: TUCATINIB; REGISTRATION NO/DATE: EU/1/20/1526 (MITTEILUNG) 20210212 |
| 1971601 | C 2021 022 | Romania | ⤷ Try a Trial | PRODUCT NAME: TUCATINIB OPTIONAL SUB FORMA DE SARE ACCEPTABILA FARMACEUTIC SAU SOLVAT; NATIONAL AUTHORISATION NUMBER: EU/1/20/1526; DATE OF NATIONAL AUTHORISATION: 20210211; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1526; DATE OF FIRST AUTHORISATION IN EEA: 20210211 |
| 1971601 | 122021000042 | Germany | ⤷ Try a Trial | PRODUCT NAME: TUCATINIB UND SEINE PHYSIOLOGISCH VERTRAEGLICHEN SALZE UND SOLVATE; REGISTRATION NO/DATE: EU/1/20/1526 20210211 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
